OR7E154P

Across TCGA pan-cancer cohorts, OR7E154P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR7E154P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR7E154P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E154P expression acts as an unfavorable survival marker.

COAD, THCA, and ESCA are the cancer types where OR7E154P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.283	0.810	.001	81	view →
THCA	DFS	Tertile	II,III,IV	0.061	0.730	<.001	36	view →
ESCA	OS	Tertile	All	0.507	0.720	.013	27	view →
THYM	OS	Tertile	All	0.381	0.879	.003	24	view →
SKCM	OS	Tertile	All	0.278	0.787	.012	18	view →
LAML	DFS	Tertile	All	0.181	0.577	.037	18	view →
SARC	OS	Tertile	All	0.183	0.747	<.001	18	view →
STAD	OS	Tertile	II,III,IV	0.428	0.682	.016	15	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR7E154P–COAD (OS)

Open the COAD breakdown →